drug designing- jaideep sarkar
TRANSCRIPT
-
8/3/2019 Drug Designing- JAIDEEP SARKAR
1/25
A
H G
B
C
D
E
F
Drug Design(DOCKING)
R
P
By:
JAIDEEP SARKAR
-
8/3/2019 Drug Designing- JAIDEEP SARKAR
2/25
High Throughput Screeningp104 ligands per day
Drug Des ign
But: Hit Rate 10-6 per ligand
-
8/3/2019 Drug Designing- JAIDEEP SARKAR
3/25
RATIONAL DRUG D E S I GN
Compound
databases,
Microbial broths,
Plants extracts,
Combinatorial
Libraries
3-D ligand
Databases
Docking
Linking or
Binding
Receptor-Ligand
Complex
Random
screening
synthesis
Lead molecule
3-D QSAR
Target Enzyme
OR Receptor
3-D structure by
Crystallography,NMR, electron
microscopy OR
Homology Modeling
Redesign
to improve
affinity,
specificity etc.
Testing
-
8/3/2019 Drug Designing- JAIDEEP SARKAR
4/25
Structure specific drugs
Act at specific sites (receptor or enzyme)-Activity/potency susceptible to small changes in
structure
Ex.- It took Pfizer about 18 years to develop the anti-inflammatory drug Piroxicam, which
was launched in 1980 during the golden age of rational drug discovery
MECHANISM OF DRUGACTION
-
8/3/2019 Drug Designing- JAIDEEP SARKAR
5/25
Substrate
Protein
Ligand
BINDING
REACTION
FUNCTION
STRUCTURAL
CHANGE
-
8/3/2019 Drug Designing- JAIDEEP SARKAR
6/25
What is Docking?
Docking attempts to find the best matching between two molecules
It includes finding the Right Key for the Lock
Given two biological molecules determine:
- Whether the two molecules interact
- If so, what is the orientation that maximizes the interaction
while minimizing the total energy of the complex
Goal: To be able to search a database of molecular structures
and retrieve all molecules that can interact with the query
structure
-
8/3/2019 Drug Designing- JAIDEEP SARKAR
7/25
The Process
Identify disease
protein Identify active siteDetermine structure
of Protein
Virtual Screening of
Drug Candidates
Synthesis of Lead
Compounds
Pharmacological
Testing
Optimisation Clinical Trials Drug
-
8/3/2019 Drug Designing- JAIDEEP SARKAR
8/25
D o c k i n g P r o t o c o l
-
8/3/2019 Drug Designing- JAIDEEP SARKAR
9/25
c o n t d . . .
RANDOM START POSITION:
Creation of a decoy begins with a random orientation of
each partner and a translation of one partner along the line
of protein centers to create a glancing contact between the
proteins
-
8/3/2019 Drug Designing- JAIDEEP SARKAR
10/25
Lead Op t imiza t ion
Lead Lead OptimizationActive site
Express proteins
with changes in
amino acid
sequences
Identify amino
acids involved infunction
-
8/3/2019 Drug Designing- JAIDEEP SARKAR
11/25
Generate molecular surface of protein
Cavities in the receptor are used to
define spheres (blue); the centres
are potential locations for ligand atoms.
Sphere centres are matched to ligand
atoms, to determine possible orientations
for the ligand. 104 orientations generated
How DOCK works.
-
8/3/2019 Drug Designing- JAIDEEP SARKAR
12/25
Virtual screening, toidentify potential leadcompounds from a large
dataset Known structures of organic
compounds
Libraries of Virtual Compounds
Programs calculate affinity forprotein
Narrow down to small number of
possiblities
Surfacerepresentation thatefficiently represents the docking
surface and identifies the regions of
interest (cavities and protrusions)
Surface matching that matches
surfaces to optimize a binding score
-
8/3/2019 Drug Designing- JAIDEEP SARKAR
13/25
Poseprediction
If we know exactly
where and how aknown ligand binds...
We can see which
parts are importantfor binding
We can suggest
changes to improve
affinity
Avoid changes that
will clash with the
protein
-
8/3/2019 Drug Designing- JAIDEEP SARKAR
14/25
Monte Carlo methods (MC)
Molecular Dynamics (MD)
Simulated Annealing (SA)
Genetic Algorithms (GA)
Available in packages:
Auto Dock (MC,GA,SA)
GOLD (GA)
Sybyl (MD)
Rosetta DOCK (Baker ,
Washington Univ., Gray,
Johns Hopkins Univ.)
Introducing flexibility:
Whole molecule docking programs
Glide (Schrodinger)
-
8/3/2019 Drug Designing- JAIDEEP SARKAR
15/25
Why is docking important?
It is the key to rational drug design: The results of
docking can be used to find inhibitors for specific
target proteins and thus to design new drugs. It isgaining importance as the number of proteins
whose structure is known increases
In addition to new drug discovery, it is of extreme
relevance in cellular biology, where function isaccomplished by proteins interacting with
themselves and with other molecular components
-
8/3/2019 Drug Designing- JAIDEEP SARKAR
16/25
M o d i f i e d Simple A l g o r i t h m a n d 3D
Superposi t ion and A l ignment
-
8/3/2019 Drug Designing- JAIDEEP SARKAR
17/25
Drug Discovery by Drug Designing
Case Study: Tuberculosis
Crystals &
Crystal structure
Lead compound
Virtual Screening
Combinatorial chemistryEnzyme assay
-0.006 -0.004 -0.002 0 0.002 0.004 0.006 0.008 0.010 0.012 0.014-1
0
1
2
3
4
5
6
7AccD5-NCI65828
1/[Malonyl-CoA]um-1
1/Vo(min-1
)
[I] = 0.00
[I] = 2.50
[I] = 5.00
[I] =10.00
TB ACCase,AccD5
-
8/3/2019 Drug Designing- JAIDEEP SARKAR
18/25
Docking
The Computational Loop -
Similarity Search
-
8/3/2019 Drug Designing- JAIDEEP SARKAR
19/25
Structure-Based Drug Design
Identified AccD5 Inhibitors
New TB drug lead
HO3S
NH2
N
N
OH
-
8/3/2019 Drug Designing- JAIDEEP SARKAR
20/25
Why i s th i s d i f f i cu l t? Both molecules are flexible and may alter each others
structure as they interact:
Hundreds to thousands of degrees of freedom (DOF)
Total possible conformations are astronomical
-
8/3/2019 Drug Designing- JAIDEEP SARKAR
21/25
Trypsinogen
Trypsin
Chymotrypsinogen
Chymotrypsin
Duodenal Cell
Enterokinase
-
8/3/2019 Drug Designing- JAIDEEP SARKAR
22/25
USES OF DOCKING
Drug targets Protein- ligand interactions that otherwise may be
overlooked
Better understand the Machinery ofLife
Enzyme-inhibitor class
Antibody-antigen class
Others
Protein Therapies
Engineered Protein Enzymes Although the reliability of docking methods is not so
high, they can provide new suggestions
False positives rates can be reduced using several scoring
functions in a consensus-scoring strategy
-
8/3/2019 Drug Designing- JAIDEEP SARKAR
23/25
Large tomatoes can evolve from wild,blueberry-size tomatoes. The genetic
mechanism responsible for this is
similar to the one that proliferates
cancer cells in mammalians. That's a
connection nobody could have made
in the past.
Cancer cell growth appears to be related to
evolutionary development of plump fruits and
vegetables
ADVANCE USE.
-
8/3/2019 Drug Designing- JAIDEEP SARKAR
24/25
Future Challenges For Docking
Better Scoring Functions
High-Throughput Screening
Tractable Models ofFlexibility
The so-called computational molecular docking problem is farfrom being solved. There are two major bottle-necks:
1. The algorithms can handle only a limited extent of
backbone flexibility2. The availability of selective and efficient scoring
functions
-
8/3/2019 Drug Designing- JAIDEEP SARKAR
25/25